Literature DB >> 16565906

Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease.

D M Stone1, D A C Frattarelli, S Karthikeyan, Y R Johnson, K Chintala.   

Abstract

We describe a neonate with ductal-dependent congenital heart disease on extracorporeal membrane oxygenation (ECMO) for persistent pulmonary hypertension, who required markedly high doses of prostaglandin E1 (PGE1) to maintain patency of the ductus arteriosus: The effects of ECMO on the pharmacokinetics of PGE1 are discussed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16565906     DOI： 10.1007/s00246-005-1189-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  13 in total

Review 1.  ECMO and pharmacotherapy.

Authors:  B Noerr
Journal:  Neonatal Netw       Date:  1996-09

2.  Extracorporeal membrane oxygenation and neonatal respiratory failure: experience from the extracorporeal life support organization.

Authors:  C J Stolar; S M Snedecor; R H Bartlett
Journal:  J Pediatr Surg       Date:  1991-05       Impact factor: 2.545

3.  Extracorporeal Membrane Oxygenation as a Bridge to Cardiac Transplantation in Children.

Authors:  Kozo Ishino; Yuguo Weng; Vladimir Alexi-Meskishvili; Matthias Loebe; Frank Uhlemann; Peter E Lange; Roland Hetzer
Journal:  Artif Organs       Date:  1996-05       Impact factor: 3.094

Review 4.  Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates.

Authors:  Marcia L Buck
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Extracorporeal membrane oxygenation for postoperative cardiac support in children.

Authors:  K R Kanter; G Pennington; T R Weber; M A Zambie; P Braun; V Martychenko
Journal:  J Thorac Cardiovasc Surg       Date:  1987-01       Impact factor: 5.209

6.  The influence of ductal left-to-right shunting during extracorporeal membrane oxygenation.

Authors:  R Tanke; O Daniels; A Van Heyst; H Van Lier; C Festen
Journal:  J Pediatr Surg       Date:  2002-08       Impact factor: 2.545

7.  Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs.

Authors:  O Dagan; J Klein; C Gruenwald; D Bohn; G Barker; G Koren
Journal:  Ther Drug Monit       Date:  1993-08       Impact factor: 3.681

8.  Extracorporeal membrane oxygenation for cardiac rescue in children with severe myocardial dysfunction.

Authors:  H J Dalton; R D Siewers; B P Fuhrman; P Del Nido; A E Thompson; M G Shaver; M Dowhy
Journal:  Crit Care Med       Date:  1993-07       Impact factor: 7.598

9.  Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases.

Authors:  R H Bartlett; A F Andrews; J M Toomasian; N J Haiduc; A B Gazzaniga
Journal:  Surgery       Date:  1982-08       Impact factor: 3.982

10.  [The intrapulmonary metabolism of prostaglandin E1 in patients with pulmonary hypertension].

Authors:  K Arai
Journal:  Masui       Date:  1995-04
View more
  6 in total

Review 1.  Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation.

Authors:  Kevin Watt; Jennifer S Li; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  J Cardiovasc Pharmacol       Date:  2011-08       Impact factor: 3.105

2.  An extracorporeal artificial placenta supports extremely premature lambs for 1 week.

Authors:  Benjamin Bryner; Brian Gray; Elena Perkins; Ryan Davis; Hayley Hoffman; John Barks; Gabe Owens; Martin Bocks; Alvaro Rojas-Peña; Ronald Hirschl; Robert Bartlett; George Mychaliska
Journal:  J Pediatr Surg       Date:  2014-12-07       Impact factor: 2.545

3.  The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.

Authors:  Enno D Wildschut; Annewil van Saet; Pavla Pokorna; Maurice J Ahsman; John N Van den Anker; Dick Tibboel
Journal:  Pediatr Clin North Am       Date:  2012-08-29       Impact factor: 3.278

4.  A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation.

Authors:  S Mousavi; B Levcovich; M Mojtahedzadeh
Journal:  Daru       Date:  2011       Impact factor: 3.117

5.  Therapeutic effect of prostaglandin E1 in monocrotaline-induced pulmonary arterial hypertension rats.

Authors:  Jae Chul Lee
Journal:  Anat Cell Biol       Date:  2017-03-29

6.  Re: An unusual migratory polycyclic eruption after administration of prostaglandin E in a neonate.

Authors:  Lee Wheless; Laura E Murray; Fariha Siddiqui; Jeffrey D Byers
Journal:  JAAD Case Rep       Date:  2017-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.